Fibrosis News and Research

RSS

Fibrosis is the growth of fibrous tissue.

Genetic factors may play a role in progression of liver injury in Caucasians with hepatitis B infection

A new study has shown that genetic variation may increase the risk of severe liver damage in Caucasians with chronic hepatitis B infection.

27 Jul 2018

Researchers develop nano-carriers to specifically target senescent cells

Senescent cells are damaged cells that do not perform their normal roles anymore but that are not dead -hence they are commonly known as zombi cells.

27 Jul 2018

New target for pneumonia seems to restore tight barriers and fluid clearance in the lungs

Severe pneumonia causes a buildup of fluid in the lungs that makes the basics of breathing and getting oxygen out to the body difficult to impossible.

25 Jul 2018

Researchers investigate recessive genetic disorder that leads to childhood blindness

Our genome is made up of 20,000 genes, all of which may cause disease. At present, 4,141 genes have been identified as being responsible for genetic abnormalities, leaving around 16,000 genes with unknown implication in disease.

23 Jul 2018

UC San Diego researchers awarded two grants for investigating stem cell-based therapies

The governing board of the California Institute for Regenerative Medicine unanimously approved this week two grants worth more than $2.2 million to University of California San Diego School of Medicine researchers investigating stem cell-based therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of the lungs.

20 Jul 2018

Studies highlight issues regarding black lung, opioid overdose, police violence and more

This study found the national prevalence of coal worker's pneumoconiosis (black lung) is increasing among working coal miners. In central Appalachia, 20.6 percent of miners working more than 25 years have black lung disease.

20 Jul 2018

Top AI companies join hands to discover novel drugs for DMD

Insilico Medicine a leader in artificial intelligence for drug discovery, biomarker development and aging research, announced a research collaboration agreement with A2A Pharmaceuticals, Inc. A2A is a biotechnology company headquartered in New York and focused on development of novel drugs for unmet needs in oncology, drug resistant bacterial infections, and other life threatening diseases.

20 Jul 2018

Study finds link between DNA methylation and non-alcoholic fatty liver disease

DNA methylation is a molecular process that helps enable our bodies to repair themselves, fight infection, get rid of environmental toxins, and even to think. But sometimes this process goes awry.

19 Jul 2018

A simple pill for meth addicts on the cards

Researchers from Australia's Curtin University have developed a simple pill that could be used to treat methamphetamine addicts. It would soon be tried in a clinical trial to prove its efficacy and utility said the researchers.

18 Jul 2018

Novel delivery system for bacteriophages could offer new way to battle lung infections

A new delivery system for bacteriophages - viruses that selectively attack harmful bacteria - could help give doctors a new way to battle lung infections that threaten older patients and people with cystic fibrosis.

17 Jul 2018

Researchers find experimental compound to treat fibrotic diseases

Normal scar tissue forms to heal an internal wound and quietly retreats when the job is done. But in many common diseases - kidney, liver and lung fibrosis -- the scar tissue goes rogue and strangles vital organs. These diseases are largely untreatable and ultimately fatal.

13 Jul 2018

Component of cinnamon oil can help treat certain bacterial infections

Researchers have found that a major component of cinnamon oil can help to clear certain bacterial infections.

12 Jul 2018

People with type 2 diabetes more likely to suffer from breathlessness, restrictive lung disease

Breathlessness and conditions of restrictive lung disease (RLD), such as pulmonary fibrosis, may be a late complication of type 2 diabetes.

11 Jul 2018

Researchers use gene therapy to cure obesity and type 2 diabetes in mice

A research team from the UAB led by Professor Fatima Bosch has managed to cure obesity and type 2 diabetes in mice using gene therapy.

9 Jul 2018

State prisons fail to offer cure to 144,000 inmates with deadly hepatitis C

State prisons across the U.S. are failing to treat at least 144,000 inmates who have hepatitis C, a curable but potentially fatal liver disease, according to a recent survey and subsequent interviews of state corrections departments.

9 Jul 2018

Bacteria adapted to the human body may become more susceptible to antibiotics

A new study published today in Nature Communications, led by scientists at the University of Liverpool in collaboration with the University of Salford, finds evidence that as bacteria adapt to the human body, they can sometimes become more susceptible to antibiotics and therefore easier to kill.

6 Jul 2018

Established lung fibrosis can be reversed using diabetes drug treatment

Researchers at the University of Alabama at Birmingham have shown - for the first time - that established lung fibrosis can be reversed using a drug treatment that targets cell metabolism.

2 Jul 2018

Antioxidant-enriched vitamin may decrease exacerbations in cystic fibrosis patients

An antioxidant-enriched vitamin may decrease respiratory exacerbations in people with cystic fibrosis(CF), according to new research published online in April in the American Journal of Respiratory and Critical Care Medicine.

2 Jul 2018

Researchers develop inexpensive blood test to diagnose hepatitis B patients

A simple $20 blood test could help diagnose thousands of patients with hepatitis B in need of treatment in some of Africa's poorest regions.

2 Jul 2018

Study finds that several existing anti-cancer drugs may work in part by binding to RNA

Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti-cancer drugs may work, in part, by binding tightly to RNA, the regulators of the basic activities of life within cells.

30 Jun 2018

Fibrosis News and Research

Further Reading

Genetic factors may play a role in progression of liver injury in Caucasians with hepatitis B infection

Researchers develop nano-carriers to specifically target senescent cells

New target for pneumonia seems to restore tight barriers and fluid clearance in the lungs

Researchers investigate recessive genetic disorder that leads to childhood blindness

UC San Diego researchers awarded two grants for investigating stem cell-based therapies

Studies highlight issues regarding black lung, opioid overdose, police violence and more

Top AI companies join hands to discover novel drugs for DMD

Study finds link between DNA methylation and non-alcoholic fatty liver disease

A simple pill for meth addicts on the cards

Novel delivery system for bacteriophages could offer new way to battle lung infections

Researchers find experimental compound to treat fibrotic diseases

Component of cinnamon oil can help treat certain bacterial infections

People with type 2 diabetes more likely to suffer from breathlessness, restrictive lung disease

Researchers use gene therapy to cure obesity and type 2 diabetes in mice

State prisons fail to offer cure to 144,000 inmates with deadly hepatitis C

Bacteria adapted to the human body may become more susceptible to antibiotics

Established lung fibrosis can be reversed using diabetes drug treatment

Antioxidant-enriched vitamin may decrease exacerbations in cystic fibrosis patients

Researchers develop inexpensive blood test to diagnose hepatitis B patients

Study finds that several existing anti-cancer drugs may work in part by binding to RNA

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News